Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
Accuray And The University of Wisconsin School of Medicine and Public Health Announce A New 10-Year Strategic Collaboration To Advance Personalized Cancer Treatments Using Accuray's Stellar Adaptive Radiation Therapy Platform
Accuray Inc (ARAY) Runs Into Middle East Headwinds, But Shift Plan Is Working
Jefferies Downgrades Accuray to Hold, Lowers Price Target to $0.35
Accuray Slides As Insider Purchases Lose Another US$95k
BTIG Downgrades Accuray to Neutral
Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript
Accuray Incorporated 2026 Q3 - Results - Earnings Call Presentation
Accuray (ARAY) Q3 2026 Earnings Transcript
Accuray Q3 Earnings Call Highlights
Accuray Inc (NASDAQ:ARAY) Plunges 12.5% After Fiscal Q3 Earnings Miss
Accuray Reports Fiscal 2026 Third Quarter Financial Results
Accuray Withdraws FY26 Financial Guidance As Geopolitical Uncertainty In Middle East Delays Installations, Materially Impacting Shipments And Service Revenue
Accuray Q3 EPS $(0.09) Misses $(0.04) Estimate, Sales $104.845M Miss $111.900M Estimate
Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
Accuray Receives Nasdaq Noncompliance Notice, Gets Time Through Aug. 3 To Regain Compliance
Groundhog Day Once Again, As Accuray Misses And Lowers
Accuray Incorporated 2026 Q2 - Results - Earnings Call Presentation
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.